teriflunomide accord
accord healthcare s.l.u. - teriflunomide - multippel sklerose, relapsing-remitting - immunosuppressants, selektiv immunosuppressants - teriflunomide accord is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).
apocillin 165 mg
actavis group ptc ehf (1) - fenoksymetylpenicillinkalium - tablett, filmdrasjert - 165 mg
diclocil 1 g
bristol-myers squibb ab - dikloksacillinnatrium - pulver til injeksjons-/infusjonsvæske, oppløsning - 1 g
apocillin 330 mg
actavis group ptc ehf (1) - fenoksymetylpenicillinkalium - tablett, filmdrasjert - 330 mg
apocillin 250 mg/ ml
actavis group ptc ehf (1) - fenoksymetylpenicillinkalium - granulat til dråper, oppløsning - 250 mg/ ml
apocillin 50 mg/ ml
actavis group ptc ehf (1) - fenoksymetylpenicillinkalium - granulat til mikstur, oppløsning - 50 mg/ ml
apocillin 1 g
actavis group ptc ehf (1) - fenoksymetylpenicillinkalium - tablett, filmdrasjert - 1 g
apocillin 660 mg
actavis group ptc ehf (1) - fenoksymetylpenicillinkalium - tablett, filmdrasjert - 660 mg
cloxacillin navamedic nordic 2 g
navamedic asa - kloksacillinnatrium - pulver til injeksjons-/infusjonsvæske, oppløsning - 2 g
cloxacillin navamedic nordic 1 g
navamedic asa - kloksacillinnatrium - pulver til injeksjons-/infusjonsvæske, oppløsning - 1 g